ArticleNeurology(R) neuroimmunology & neuroinflammation2023

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.

Christian Barro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.